The development in vivo siRNA delivery system for the treatment of renal fibrosis
| Project/Area Number |
23659026
|
|---|
| Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Physical pharmacy
|
|---|
| Research Institution | Jichi Medical University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2011 – 2012
|
| Project Status |
Completed (Fiscal Year 2012)
|
| Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2012: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2011: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
|
|---|
| Keywords | ドラッグデリバリー / 遺伝子治療 / 腎線維化 / siRNA / ドラッグ・デリバリ- |
|---|
| Research Abstract |
1) We detected that smad4-siRNA could significantly inhibit the epithelial mesenchymal transition of HK-2 cells with stimulation of TGF-β1.
2) We intravenously injected modified smad4-siRNA that was added extra bases at 5 prime of antisense strand and at 3 prime of sense strand to increase its stability in vivo (stable-smad4-siRNA) to renal fibrosismice. We detected t
|
Report
(3 results)
Research Products
(4 results)
